Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.

Author: , CahallDavid, DelmasPierre D, EastellRichard, GrauerAndreas, PolsHuibert A P, RingeJohann D, RouxChristian, VrijensBernard, WattsNelson B

Paper Details 
Original Abstract of the Article :
CONTEXT: Persistence with osteoporosis treatment is poor but is important for maximum benefit. OBJECTIVE: The objective of the study was to assess the impact of physician reinforcement using bone turnover markers (BTMs) on persistence with risedronate treatment. DESIGN AND SETTING: This was a 1-yr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1210/jc.2006-1526

データ提供:米国国立医学図書館(NLM)

Risedronate for Osteoporosis: Navigating the Desert of Bone Health

Osteoporosis, a condition characterized by weak and brittle bones, is like a desert landscape, prone to fractures. This study investigates the impact of bone turnover markers (BTMs) on persistence with risedronate treatment for postmenopausal osteoporosis.

The researchers conducted a multinational, prospective study examining the effects of reinforcement using BTMs on persistence with risedronate treatment. They found that reinforcement based on good BTM response significantly improved persistence, suggesting that monitoring BTMs can be a valuable tool for navigating the desert of osteoporosis treatment.

Monitoring BTMs: Finding the Right Path in Osteoporosis

This research highlights the potential of monitoring BTMs to improve persistence with risedronate treatment for osteoporosis. By providing personalized feedback based on BTMs, clinicians can guide patients on the most effective path through the desert of osteoporosis treatment, ensuring optimal bone health and reducing the risk of fractures.

Dr. Camel's Conclusion

Osteoporosis, like a vast desert landscape, can be a challenging condition for women. This study explores the role of bone turnover markers (BTMs) in improving persistence with risedronate treatment. The researchers have meticulously investigated the impact of monitoring BTMs, highlighting their ability to guide patients on the most effective path through the desert of osteoporosis treatment. This research offers a valuable roadmap for navigating this challenging condition, ensuring optimal bone health and reducing the risk of fractures.

Date :
  1. Date Completed 2007-09-17
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17244788

DOI: Digital Object Identifier

10.1210/jc.2006-1526

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.